Spyre Therapeutics, Inc. Common Stock SYRE
$78.63
-2.26%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 8-K | 8-K | 2026-10-07 | View → |
| 424B5 | 424B5 | 2026-10-06 | View → |
| 424B5 | 424B5 | 2026-10-05 | View → |
| 4 | FORM 4 | 2026-10-02 | View → |
| 4 | FORM 4 | 2026-10-02 | View → |
| 4 | FORM 4 | 2026-10-02 | View → |
| 8-K | 8-K | 2026-09-08 | View → |
| 4 | FORM 4 | 2026-09-03 | View → |
| 4 | FORM 4 | 2026-09-03 | View → |
| 4 | FORM 4 | 2026-09-03 | View → |
| 8-K | 8-K | 2026-08-25 | View → |
| 4 | FORM 4 | 2026-08-10 | View → |
| 4 | FORM 4 | 2026-08-05 | View → |
| 4 | FORM 4 | 2026-08-05 | View → |
| 8-K | 8-K | 2026-08-04 | View → |
| 10-Q | 10-Q | 2026-08-04 | View → |
| 4 | FORM 4 | 2026-07-02 | View → |
| 4 | FORM 4 | 2026-07-02 | View → |
| 4 | FORM 4 | 2026-07-02 | View → |
| 4 | FORM 4 | 2026-06-26 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-23 | View → |
| 4 | FORM 4 | 2026-06-23 | View → |
| 8-K | 8-K | 2026-06-15 | View → |
| 4 | FORM 4 | 2026-06-03 | View → |
| 4 | FORM 4 | 2026-06-03 | View → |
| 4 | FORM 4 | 2026-06-03 | View → |
| 8-K | 8-K | 2026-06-01 | View → |
| 4 | FORM 4 | 2026-05-29 | View → |
| 4 | FORM 4 | 2026-05-29 | View → |
| 4 | FORM 4 | 2026-05-29 | View → |
| 4 | FORM 4 | 2026-05-29 | View → |
| 4 | FORM 4 | 2026-05-29 | View → |
| 4 | FORM 4 | 2026-05-29 | View → |
| 8-K | 8-K | 2026-05-29 | View → |
| 4 | FORM 4 | 2026-05-08 | View → |
| 8-K | 8-K | 2026-05-05 | View → |
| 10-Q | 10-Q | 2026-05-05 | View → |
| 4 | FORM 4 | 2026-05-01 | View → |
| 4 | FORM 4 | 2026-05-01 | View → |
| 4 | FORM 4 | 2026-05-01 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $78.63
- Market Cap
- $7.52 billion
- 52-Week Range
- $14.51 – $110.17
- Average Volume
- 1.44 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.